News

GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...
What Happened? A number of stocks fell in the afternoon session after the major indices continued to pull back, with technology stocks accounting for most of the market's largest decliners. A key ...
A draft copy of an upcoming MAHA report reveals a strategy in lockstep with recent HHS actions such as reviving the Task ...
Investing.com - TD Cowen has lowered its price target on Novo Nordisk (NYSE: NVO) to $70.00 from $105.00 while maintaining a Buy rating on the stock. The new target sits within the broader analyst ...
Why aren't all drugs covered by insurance? A formulary is the list of prescription medications covered by a health insurance plan. Research by GoodRx, a platform for medication savings, found that ...
Demystify drug coverage. Learn the business and clinical reasons why some medications are covered by insurance and others ...